Your browser doesn't support javascript.
loading
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
Van Damme, Pierre; De Coster, Ilse; Bandyopadhyay, Ananda S; Revets, Hilde; Withanage, Kanchanamala; De Smedt, Philippe; Suykens, Leen; Oberste, M Steven; Weldon, William C; Costa-Clemens, Sue Ann; Clemens, Ralf; Modlin, John; Weiner, Amy J; Macadam, Andrew J; Andino, Raul; Kew, Olen M; Konopka-Anstadt, Jennifer L; Burns, Cara C; Konz, John; Wahid, Rahnuma; Gast, Christopher.
Afiliación
  • Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. Electronic address: pierre.vandamme@uantwerpen.be.
  • De Coster I; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Revets H; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Withanage K; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • De Smedt P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Suykens L; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
  • Oberste MS; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Weldon WC; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Costa-Clemens SA; Institute for Global Health, University of Siena, Siena, Italy.
  • Clemens R; Global Research in Infectious Diseases, Rio de Janeiro, Brazil.
  • Modlin J; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Weiner AJ; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Macadam AJ; National Institute for Biological Standards and Control, Ridge, UK.
  • Andino R; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
  • Kew OM; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Konopka-Anstadt JL; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Burns CC; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Konz J; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
  • Wahid R; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
  • Gast C; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
Lancet ; 394(10193): 148-158, 2019 07 13.
Article en En | MEDLINE | ID: mdl-31174831
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacuna Antipolio Oral / Poliovirus / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacuna Antipolio Oral / Poliovirus / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article